Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ACET | Adicet Bio, Inc. | Director, 10%+ Owner | $942 K | +$7.5 M | Jun 5, 2024 | |
KNTE | Kinnate Biopharma Inc. | Director, 10%+ Owner | $0 | Apr 3, 2024 | ||
THRX | Theseus Pharmaceuticals, Inc. | Director, 10%+ Owner | $0 | +$1.46 M | Feb 14, 2024 | |
AVBP | ArriVent BioPharma, Inc. | Director, 10%+ Owner | Jan 30, 2024 | |||
CMPX | Compass Therapeutics, Inc. | Director, 10%+ Owner | Feb 9, 2024 | |||
IRON | Disc Medicine, Inc. | Director, 10%+ Owner | Oct 4, 2021 | |||
KROS | Keros Therapeutics, Inc. | Director | May 30, 2024 | |||
ORIC | Oric Pharmaceuticals, Inc. | Director, 10%+ Owner | Jun 16, 2021 | |||
TERN | Terns Pharmaceuticals, Inc. | Director, 10%+ Owner | Jul 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|